To view this email as a web page, click here

Today's Rundown

Featured Story

Novavax kick-starts phase 3 of COVID-19 vaccine in U.K. as cases surge across the country

Novavax is starting a phase 3 trial of its pandemic vaccine hopeful NVX-CoV2373 in 10,000 adults over the next month.

read more

Top Stories

Merck, advancing single-dose and oral coronavirus vaccines, could still make Warp Speed: Bloomberg

The U.S. government’s Operation Warp Speed has already inked COVID-19 vaccine research and manufacturing pacts with major players—excluding Merck & Co., that is. But the group’s description of an as-yet-unnamed vaccine participant matches Merck’s early-stage research, Bloomberg reports.  

read more

United Airlines teams up with Color to make COVID-19 tests available to passengers

United Airlines is working with health technology and genomics company Color to roll out the first COVID-19 testing program for air travelers. The airline will offer COVID-19 tests—either rapid tests at the airport or mail-in at-home tests prior to travel—to passengers flying from San Francisco International Airport to Hawaiian airports beginning Oct. 15.

read more

How Anthem, Humana quickly moved to meet food insecurity needs of MA members due to COVID-19

Insurers Anthem and Humana have revved up efforts to improve food insecurity among their Medicare Advantage members in the wake of the COVID-19 pandemic.

read more

Biopharma roundup: Vaccine safety pledge buoys pharma's rep

United Airlines will start screening passengers on certain routes with Abbott's rapid swab test for COVID-19. Americans aware of a recent vaccine safety pledge by nine drugmakers had a more positive view of those companies, a new Harris Poll found. And China scored backing from the WHO before starting its emergency use vaccine program, a Chinese health official said.

read more

Sam's Club membership now comes with telehealth perk

The membership warehouse club—which is a division of Walmart—is expanding a telehealth discount with virtual care provider 98point6 to all members after a yearlong pilot.

read more

As phase 3 kicks off, Novavax and Endo ink manufacturing pact for COVID-19 vaccine

Maryland biotech Novavax has kicked off late-stage testing for its COVID-19 shot in the U.K. as the hunt for a vaccine hits critical mass—and its U.S. and India trials aren't far behind. To help supply those pivotal trials and a potential commercial rollout, Novavax is partnering with a major generics player.

read more

COVID-19's impact on Medicare Advantage star ratings still murky: experts

The potential long-term impacts of COVID-19 on how Medicare Advantage's star ratings are calculated remain unclear, experts say.

read more